CME Group Inc. (NASDAQ:CME) Receives $283.71 Consensus Target Price from Analysts

CME Group Inc. (NASDAQ:CME) has received a consensus rating of “Hold” from the sixteen research firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $283.7143.

Several equities analysts have issued reports on CME shares. Deutsche Bank Aktiengesellschaft cut their target price on CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research note on Thursday, October 9th. JPMorgan Chase & Co. lifted their target price on CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday, October 14th. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Piper Sandler lifted their target price on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Finally, UBS Group cut their target price on CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th.

Insider Buying and Selling

In other news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William R. Shepard purchased 262 shares of the company’s stock in a transaction dated Thursday, September 25th. The shares were acquired at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. The trade was a 0.10% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 13,043 shares of company stock worth $3,527,956 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

A number of large investors have recently modified their holdings of CME. GAMMA Investing LLC grew its stake in shares of CME Group by 24.5% during the first quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock worth $1,859,000 after acquiring an additional 1,381 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of CME Group by 63.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider’s stock worth $27,867,000 after acquiring an additional 40,592 shares during the last quarter. Dynamic Advisor Solutions LLC grew its stake in shares of CME Group by 3.1% during the first quarter. Dynamic Advisor Solutions LLC now owns 2,533 shares of the financial services provider’s stock worth $672,000 after acquiring an additional 76 shares during the last quarter. Ritholtz Wealth Management grew its stake in shares of CME Group by 10.3% during the first quarter. Ritholtz Wealth Management now owns 4,451 shares of the financial services provider’s stock worth $1,181,000 after acquiring an additional 416 shares during the last quarter. Finally, Brighton Jones LLC purchased a new stake in shares of CME Group during the first quarter worth about $320,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $267.93 on Thursday. The firm has a market cap of $96.56 billion, a P/E ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 12 month low of $213.94 and a 12 month high of $290.79. The stock’s fifty day moving average price is $267.30 and its 200-day moving average price is $271.38.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the firm posted $2.56 earnings per share. On average, equities research analysts expect that CME Group will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.